These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 29719870)
1. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets. Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ mSystems; 2018; 3(3):. PubMed ID: 29719870 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital. Pandey R; Mishra SK; Shrestha A Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. Santajit S; Indrawattana N Biomed Res Int; 2016; 2016():2475067. PubMed ID: 27274985 [TBL] [Abstract][Full Text] [Related]
7. Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens. Zohra T; Numan M; Ikram A; Salman M; Khan T; Din M; Salman M; Farooq A; Amir A; Ali M Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33946643 [TBL] [Abstract][Full Text] [Related]
8. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital. Flores-Paredes W; Luque N; Albornoz R; Rojas N; Espinoza M; Pons MJ; Ruiz J Infect Chemother; 2021 Sep; 53(3):449-462. PubMed ID: 34508324 [TBL] [Abstract][Full Text] [Related]
9. Comparison of CRISPR-Cas Immune Systems in Healthcare-Related Pathogens. Mortensen K; Lam TJ; Ye Y Front Microbiol; 2021; 12():758782. PubMed ID: 34759910 [TBL] [Abstract][Full Text] [Related]
10. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform. Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of medicinal plants against ESKAPE: An update. Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642 [TBL] [Abstract][Full Text] [Related]
12. Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors. Verma P; Tiwari M; Tiwari V Microb Pathog; 2021 Mar; 152():104766. PubMed ID: 33545327 [TBL] [Abstract][Full Text] [Related]
13. Coping with the ESKAPE pathogens: Evolving strategies, challenges and future prospects. Aloke C; Achilonu I Microb Pathog; 2023 Feb; 175():105963. PubMed ID: 36584930 [TBL] [Abstract][Full Text] [Related]
14. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania. Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670 [TBL] [Abstract][Full Text] [Related]
15. Bacteriophages for ESKAPE: role in pathogenicity and measures of control. Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536 [TBL] [Abstract][Full Text] [Related]
16. Bacterial Antibiotic Resistance: The Most Critical Pathogens. Mancuso G; Midiri A; Gerace E; Biondo C Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684258 [TBL] [Abstract][Full Text] [Related]
17. Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens. Das S; Bombaywala S; Srivastava S; Kapley A; Dhodapkar R; Dafale NA Environ Sci Pollut Res Int; 2022 Jun; 29(27):40507-40519. PubMed ID: 35349073 [TBL] [Abstract][Full Text] [Related]
18. How Structure-Function Relationships of 1,4-Naphthoquinones Combat Antimicrobial Resistance in Multidrug-Resistant (MDR) Pathogens. Mone NS; Syed S; Ravichandiran P; Satpute SK; Kim AR; Yoo DJ ChemMedChem; 2023 Jan; 18(2):e202200471. PubMed ID: 36316281 [TBL] [Abstract][Full Text] [Related]
19. Alternatives for the treatment of infections caused by ESKAPE pathogens. da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305 [TBL] [Abstract][Full Text] [Related]
20. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections. Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]